Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Chinese Pharmacological Bulletin ; (12): 1859-1866, 2023.
Artículo en Chino | WPRIM | ID: wpr-1013692

RESUMEN

Aim To investigate the involvement and mechanism of miR-619-5p in the proliferation, migration and invasion of human breast cancer cells. Methods The expression of miR-619-5p in breast cancer and normal breast tissue and cells was detected using bioinformatic analysis or qRT-PCR. After transfection with miR-619-5p mimics or inhibitors, the expression of miR-619-5p and EMT-related molecule mRNA was determined by qRT-PCR. Cell proliferation was detected using CCK-8 assay; cell migration and invasion capacity was estimated by the wound healing assay and Transwell assay. The protein levels of EMT-related molecules were analyzed by Western blot. The target genes of miR-619-5p were analyzed by bioinformatic a-nalysis, and a preliminary analysis of the potential target gene CREB1 was carried out. Results miR-619-5p was low expressed in breast cancer tissues and breast cancer cells. Compared with the control group, over-expression of miR-619-5p resulted in up-regula-tion of miR-619-5p expression levels and EMT epithelial markers, down-regulation of pro-EMT molecules and mesenchymal markers, impairment of cell proliferation, migration and invasion, and down-regulation of CREB1 expression. The results of the low miR-619-5p expression group were opposite to the above results. Conclusions In breast cancer tissue and cells, miR-619-5p expression is lower. miR-619-5p inhibits the proliferation, migration, invasion and EMT of breast cancer cells, and its possible mechanism of the effects may be targeting CREB1.

2.
Journal of Zhejiang University. Medical sciences ; (6): 395-398, 2010.
Artículo en Chino | WPRIM | ID: wpr-319888

RESUMEN

<p><b>OBJECTIVE</b>To construct the HPV16 L1 prokaryotic expression plasmid and to optimize its expression.</p><p><b>METHODS</b>A pair of primers was designed according to plasmid sequences of pGEX-KG and the HPV16L1 genes published by GeneBank. The DNA fragment of 1500 bp was amplified by PCR from the HPV recombinant plasmid with HPV16L1 gene, then cloned into pGEX-KG and transformed into the host E.coli strain JM109. The pGEX-KG-HPV16L1 plasmid was taken and transformed into BL21(DE3) for expression. Induced by IPTG at 37 degree, the expression product of HPV16L1 gene was identified by SDS-PAGE and Western blot.</p><p><b>RESULTS</b>HPV16L1 fusion protein was expressed successfully in the form of inclusion bodies. The molecular weight was 83 kD. Meanwhile, the optimum condition of HPV16L1 fusion protein expression was induced with 1.0 mmol*L(-1) IPTG for 4 h. The fusion protein reacted specifically with antibodies against HPV16L1.</p><p><b>CONCLUSION</b>The prokaryotic expression vector of HPV16L1 gene has been constructed and expressed in E.coli successfully.</p>


Asunto(s)
Vacunas contra el Cáncer , Proteínas de la Cápside , Genética , Clonación Molecular , Escherichia coli , Genética , Metabolismo , Vectores Genéticos , Papillomavirus Humano 16 , Genética , Proteínas Oncogénicas Virales , Genética , Proteínas Recombinantes de Fusión , Genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA